ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma Article

Arrillaga-Romany, Isabel, Gardner, Sharon L, Odia, Yazmin et al. (2024). ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma . Journal of Clinical Oncology, 42(13), 10.1200/JCO.23.01134

Open Access ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Arrillaga-Romany, Isabel; Gardner, Sharon L; Odia, Yazmin; Aguilera, Dolly; Allen, Joshua E; Batchelor, Tracy; Butowski, Nicholas; Chen, Clark; Cloughesy, Timothy; Cluster, Andrew; de Groot, John; Dixit, Karan S; Graber, Jerome J; Haggiagi, Aya M; Harrison, Rebecca A; Kheradpour, Albert; Kilburn, Lindsay B; Kurz, Sylvia C; Lu, Guangrong; MacDonald, Tobey J; Mehta, Minesh; Melemed, Allen S; Nghiemphu, Phioanh Leia; Ramage, Samuel C; Shonka, Nicole; Sumrall, Ashley; Tarapore, Rohinton S; Taylor, Lynne; Umemura, Yoshie; Wen, Patrick Y

sustainable development goals

authors

publication date

  • May 1, 2024

published in

keywords

  • ADULTS
  • CHILDREN
  • DOPAMINE-RECEPTOR
  • HIGH-GRADE GLIOMAS
  • INTRINSIC PONTINE GLIOMA
  • Life Sciences & Biomedicine
  • NEUROONCOLOGY
  • Oncology
  • RESPONSE ASSESSMENT
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

volume

  • 42

issue

  • 13